RHYTHM PHARMACEUTICALS, INC. Other Non-Current Liabilities
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Other Non-Current Liabilities of $35.60 million as of 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-08-06
- 2024-06-30: Other Liabilities, Noncurrent $35.60M.
- 2024-03-31: Other Liabilities, Noncurrent $34.60M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2024-06-30 | $35.60M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $34.60M 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |